2023
DOI: 10.1016/j.sampre.2023.100068
|View full text |Cite
|
Sign up to set email alerts
|

Green profile tools: Current status and future perspectives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 33 publications
(2 citation statements)
references
References 46 publications
0
2
0
Order By: Relevance
“…The ComplexGAPI tool was applied for the evaluation of the green character of the developed procedure. This metric not only allows the evaluation of the analytical protocol in terms of its environmental friendliness but also those processes which precede the analytical procedure itself ( Płotka-Wasylka and Wojnowski, 2021 ; Locatelli et al, 2023 ). And so, the greenness aspect of the following parameters was evaluated: yield, conditions, reagents and solvents, instrumentation and workup, and purification which may occur before analytical protocol.…”
Section: Resultsmentioning
confidence: 99%
“…The ComplexGAPI tool was applied for the evaluation of the green character of the developed procedure. This metric not only allows the evaluation of the analytical protocol in terms of its environmental friendliness but also those processes which precede the analytical procedure itself ( Płotka-Wasylka and Wojnowski, 2021 ; Locatelli et al, 2023 ). And so, the greenness aspect of the following parameters was evaluated: yield, conditions, reagents and solvents, instrumentation and workup, and purification which may occur before analytical protocol.…”
Section: Resultsmentioning
confidence: 99%
“…Minimal amounts of such contaminants can impact the drug's effectiveness and safety. The medicine's safety is determined not only by the toxicological qualities of the active pharmaceutical ingredient as well as by the impurities it currently incorporates [1] . Detecting, separating, and assessing these contaminants is crucial in drug manufacturing and regulatory assessments.…”
Section: Introductionmentioning
confidence: 99%